|Articles|May 9, 2018
What if Every Prescription Drug Came with an Amazon Alexa?
Author(s)Michelle Maskaly
Albert Thigpen, president and chief operating officer of CastiaRx, talks about how pharmaceuticals companies could be using devices such as Amazon’s Alexa to help improve patient adherence and the overall patient journey.His remarks come after a seminar at Asembia’s Specialty Pharmacy Summit in Las Vegas.
Advertisement
Albert Thigpen, president and chief operating officer of CastiaRx, talks about how pharmaceuticals companies could be using devices such as Amazon’s Alexa to help improve patient adherence and the overall patient journey.
His remarks come after a seminar at Asembia’s Specialty Pharmacy Summit in Las Vegas.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5